1. Home
  2. Chemical & Material
  3. Global GABA (CAS 56-12-2) Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global GABA (CAS 56-12-2) Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 154 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global GABA (CAS 56-12-2) market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the GABA (CAS 56-12-2) market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of GABA (CAS 56-12-2) in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Biological Fermentation
Chemical Synthesis

Market Snapshot, By Application
Pharmaceuticals & Food
Animal Feeds
Plants Growth Promoter
Others

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Zhejiang YiWan Biolabs
Zhejiang Tianrui Chemical
Tianjin Shijitianlong Biotech
Taizhou Xinyou Pharmaceutical & Chemical
Shanghai Richen
Sekisui Chemical
Pharma Foods International
Ningxiang Jiayuan Biology Technology
Luoyang Huarong
Kyowa Hakko
Hefei Maikeluo Biological Engineering
Hangzhou Viablife Biotech
Guangxi Hanhe Biotech
Guangdong Luckerkong Biotech
Bornsun Bioengineering
Bloomage Biotechnology Corporation Limited
Anhui Xinnuobei

The study objectives of this report are:
To study and analyze the global GABA (CAS 56-12-2) market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of GABA (CAS 56-12-2) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global GABA (CAS 56-12-2) manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the GABA (CAS 56-12-2) market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of GABA (CAS 56-12-2) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of GABA (CAS 56-12-2) are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 GABA (CAS 56-12-2) Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global GABA (CAS 56-12-2) Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and GABA (CAS 56-12-2)

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 GABA (CAS 56-12-2) Sales Channel and Distributors Analysis
3.3.1 GABA (CAS 56-12-2) Sales Channel
3.3.2 GABA (CAS 56-12-2) Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 GABA (CAS 56-12-2) Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 GABA (CAS 56-12-2) Type Introduction
4.1.1 Biological Fermentation
4.1.2 Chemical Synthesis
4.2 Global GABA (CAS 56-12-2) Sales by Type 2016-2021
4.3 Global GABA (CAS 56-12-2) Revenue by Type 2016-2021
4.4 Global GABA (CAS 56-12-2) Price by Type 2016-2021

5 Market Segment: by Application
5.1 GABA (CAS 56-12-2) Type Introduction
5.1.1 Pharmaceuticals & Food
5.1.2 Animal Feeds
5.1.3 Plants Growth Promoter
5.1.3 Others
5.2 Global GABA (CAS 56-12-2) Sales by Application 2016-2021
5.3 Global GABA (CAS 56-12-2) Revenue by Application 2016-2021
5.4 Global GABA (CAS 56-12-2) Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global GABA (CAS 56-12-2) Market by Region
6.1.1 Global GABA (CAS 56-12-2) Sales by Regions
6.1.2 Global GABA (CAS 56-12-2) Revenue by Regions
6.2 North America GABA (CAS 56-12-2) Market 2016-2021
6.3 Europe GABA (CAS 56-12-2) Market 2016-2021
6.4 Asia Pacific GABA (CAS 56-12-2) Market 2016-2021
6.5 South America GABA (CAS 56-12-2) Market 2016-2021
6.6 Middle East and Africa GABA (CAS 56-12-2) Market 2016-2021

7 North America
7.1 North America GABA (CAS 56-12-2) Market by Country 2016-2021
7.1.1 North America GABA (CAS 56-12-2) Sales by Country
7.1.2 North America GABA (CAS 56-12-2) Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe GABA (CAS 56-12-2) Market by Country 2016-2021
8.1.1 Europe GABA (CAS 56-12-2) Sales by Country
8.1.2 Europe GABA (CAS 56-12-2) Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific GABA (CAS 56-12-2) Market by Country 2016-2021
9.1.1 Asia Pacific GABA (CAS 56-12-2) Sales by Country
9.1.2 Asia Pacific GABA (CAS 56-12-2) Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America GABA (CAS 56-12-2) Market by Country 2016-2021
10.1.1 South America GABA (CAS 56-12-2) Sales by Country
10.1.2 South America GABA (CAS 56-12-2) Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa GABA (CAS 56-12-2) Market by Country 2016-2021
11.1.1 Middle East and Africa GABA (CAS 56-12-2) Sales by Country
11.1.2 Middle East and Africa GABA (CAS 56-12-2) Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Zhejiang YiWan Biolabs
12.1.1 Zhejiang YiWan Biolabs Company Information
12.1.2 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.1.3 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Zhejiang YiWan Biolabs Key Development
12.2 Zhejiang Tianrui Chemical
12.2.1 Zhejiang Tianrui Chemical Company Information
12.2.2 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.2.3 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Zhejiang Tianrui Chemical Key Development
12.3 Tianjin Shijitianlong Biotech
12.3.1 Tianjin Shijitianlong Biotech Company Information
12.3.2 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.3.3 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Tianjin Shijitianlong Biotech Key Development
12.4 Taizhou Xinyou Pharmaceutical & Chemical
12.4.1 Taizhou Xinyou Pharmaceutical & Chemical Company Information
12.4.2 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.4.3 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Taizhou Xinyou Pharmaceutical & Chemical Key Development
12.5 Shanghai Richen
12.5.1 Shanghai Richen Company Information
12.5.2 Shanghai Richen GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.5.3 Shanghai Richen GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Shanghai Richen Key Development
12.6 Sekisui Chemical
12.6.1 Sekisui Chemical Company Information
12.6.2 Sekisui Chemical GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.6.3 Sekisui Chemical GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Sekisui Chemical Key Development
12.7 Pharma Foods International
12.7.1 Pharma Foods International Company Information
12.7.2 Pharma Foods International GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.7.3 Pharma Foods International GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Sekisui Chemical Key Development
12.9 Luoyang Huarong
12.9.1 Luoyang Huarong Company Information
12.9.2 Luoyang Huarong GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.9.3 Luoyang Huarong GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Luoyang Huarong Key Development
12.8 Ningxiang Jiayuan Biology Technology
12.8.1 Ningxiang Jiayuan Biology Technology Company Information
12.8.2 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.8.3 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Ningxiang Jiayuan Biology Technology Key Development
12.11 Hefei Maikeluo Biological Engineering
12.11.1 Hefei Maikeluo Biological Engineering Company Information
12.11.2 Hefei Maikeluo Biological Engineering GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.11.3 Hefei Maikeluo Biological Engineering GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Hefei Maikeluo Biological Engineering Key Development
12.12 Hangzhou Viablife Biotech
12.12.1 Hangzhou Viablife Biotech Company Information
12.12.2 Hangzhou Viablife Biotech GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.12.3 Hangzhou Viablife Biotech GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Hangzhou Viablife Biotech Key Development
12.13 Guangxi Hanhe Biotech
12.13.1 Guangxi Hanhe Biotech Company Information
12.13.2 Guangxi Hanhe Biotech GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.13.3 Guangxi Hanhe Biotech GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 Guangxi Hanhe Biotech Key Development
12.14 Guangdong Luckerkong Biotech
12.14.1 Guangdong Luckerkong Biotech Company Information
12.14.2 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.14.3 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Guangdong Luckerkong Biotech Key Development
12.15 Bornsun Bioengineering
12.15.1 Bornsun Bioengineering Company Information
12.15.2 Bornsun Bioengineering GABA (CAS 56-12-2) Product Portfolio, Specification and Application
12.15.3 Bornsun Bioengineering GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Bornsun Bioengineering Key Development
12.17 Anhui Xinnuobei

13 Global GABA (CAS 56-12-2) Market Forecast by Region by Type and by Application
13.1 Global GABA (CAS 56-12-2) Sales, Revenue Forecast 2022-2027
13.2 Global GABA (CAS 56-12-2) Forecast by Regions
13.2.1 Global GABA (CAS 56-12-2) Sales Forecast by Region 2022-2027
13.2.2 Global GABA (CAS 56-12-2) Revenue Forecast by Region 2022-2027
13.3 Global GABA (CAS 56-12-2) Forecast by Type
13.3.1 Global GABA (CAS 56-12-2) Sales Forecast by Type 2022-2027
13.3.2 Global GABA (CAS 56-12-2) Revenue Forecast by Type 2022-2027
13.3.3 Global GABA (CAS 56-12-2) Price Forecast by Type 2022-2027
13.4 Global GABA (CAS 56-12-2) Forecast by Application
13.4.1 Global GABA (CAS 56-12-2) Sales Forecast by Application 2022-2027
13.4.2 Global GABA (CAS 56-12-2) Revenue Forecast by Application 2022-2027
13.4.3 Global GABA (CAS 56-12-2) Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global GABA (CAS 56-12-2) Production Specifications
Table 2: Drivers in GABA (CAS 56-12-2) Market
Table 3: Restraints GABA (CAS 56-12-2) Market
Table 4: Opportunity in GABA (CAS 56-12-2) Market
Table 5: Comparion of Alternative and GABA (CAS 56-12-2)
Table 6: GABA (CAS 56-12-2) Raw Materials Key Suppliers List
Table 7: GABA (CAS 56-12-2) Distributors List
Table 8: GABA (CAS 56-12-2) Major Buyers in Application One
Table 9: GABA (CAS 56-12-2) Major Buyers in Application Two
Table 10: GABA (CAS 56-12-2) Major Buyers in Application Three
Table 11: Global GABA (CAS 56-12-2) Sales (K Units) by Type 2016-2021
Table 12: Global GABA (CAS 56-12-2) Sales Market Share by Type 2016-2021
Table 13: Global GABA (CAS 56-12-2) Revenue (Million USD) by Type 2016-2021
Table 14: Global GABA (CAS 56-12-2) Revenue Market Share by Type 2016-2021
Table 15: Global GABA (CAS 56-12-2) Price by Type 2016-2021
Table 16: Global GABA (CAS 56-12-2) Sales (K Units) by Application 2016-2021
Table 17: Global GABA (CAS 56-12-2) Sales Market Share by Application 2016-2021
Table 18: Global GABA (CAS 56-12-2) Revenue (Million USD) by Application 2016-2021
Table 19: Global GABA (CAS 56-12-2) Revenue Market Share by Application 2016-2021
Table 20: Global GABA (CAS 56-12-2) Price by Application 2016-2021
Table 21: Global GABA (CAS 56-12-2) Sales (K Units) by Region 2016-2021
Table 22: Global GABA (CAS 56-12-2) Sales Market Share by Region 2016-2021
Table 23: Global GABA (CAS 56-12-2) Revenue (Million USD) by Region 2016-2021
Table 24: Global GABA (CAS 56-12-2) Revenue Market Share by Region 2016-2021
Table 25: North America GABA (CAS 56-12-2) Sales (K Units) by Country 2016-2021
Table 26: North America GABA (CAS 56-12-2) Sales Market Share by Country 2016-2021
Table 27: North America GABA (CAS 56-12-2) Revenue (Million USD) by Country 2016-2021
Table 28: North America GABA (CAS 56-12-2) Revenue Market Share by Country 2016-2021)
Table 29: Europe GABA (CAS 56-12-2) Sales (K Units) by Country 2016-2021
Table 30: Europe GABA (CAS 56-12-2) Sales Market Share by Country 2016-2021
Table 31: Europe GABA (CAS 56-12-2) Revenue (Million USD) by Country 2016-2021
Table 32: Europe GABA (CAS 56-12-2) Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific GABA (CAS 56-12-2) Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific GABA (CAS 56-12-2) Sales Market Share by Country 2016-2021
Table 35: Asia Pacific GABA (CAS 56-12-2) Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific GABA (CAS 56-12-2) Revenue Market Share by Country 2016-2021)
Table 37: South America GABA (CAS 56-12-2) Sales (K Units) by Country 2016-2021
Table 38: South America GABA (CAS 56-12-2) Sales Market Share by Country 2016-2021
Table 39: South America GABA (CAS 56-12-2) Revenue (Million USD) by Country 2016-2021
Table 40: South America GABA (CAS 56-12-2) Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa GABA (CAS 56-12-2) Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa GABA (CAS 56-12-2) Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa GABA (CAS 56-12-2) Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa GABA (CAS 56-12-2) Revenue Market Share by Country 2016-2021)
Table 45 Zhejiang YiWan Biolabs Company Information
Table 46 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Product Portfolio, Specification and Application
Table 47 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Zhejiang Tianrui Chemical Company Information
Table 49 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Product Portfolio, Specification and Application
Table 50 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Tianjin Shijitianlong Biotech Company Information
Table 52 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Product Portfolio, Specification and Application
Table 53 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Taizhou Xinyou Pharmaceutical & Chemical Company Information
Table 55 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Product Portfolio, Specification and Application
Table 56 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Shanghai Richen Company Information
Table 58 Shanghai Richen GABA (CAS 56-12-2) Product Portfolio, Specification and Application
Table 59 Shanghai Richen GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Sekisui Chemical Company Information
Table 61 Sekisui Chemical GABA (CAS 56-12-2) Product Portfolio, Specification and Application
Table 62 Sekisui Chemical GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Pharma Foods International Company Information
Table 64 Pharma Foods International GABA (CAS 56-12-2) Product Portfolio, Specification and Application
Table 65 Pharma Foods International GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Ningxiang Jiayuan Biology Technology Company Information
Table 67 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Product Portfolio, Specification and Application
Table 68 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Luoyang Huarong Company Information
Table 70 Luoyang Huarong GABA (CAS 56-12-2) Product Portfolio, Specification and Application
Table 71 Luoyang Huarong GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global GABA (CAS 56-12-2) Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global GABA (CAS 56-12-2) Sales Market Share Forecast by Region (2012-2027)
Table 74: Global GABA (CAS 56-12-2) Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global GABA (CAS 56-12-2) Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global GABA (CAS 56-12-2) Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global GABA (CAS 56-12-2) Sales Market Share Forecast by Type (2012-2027)
Table 78: Global GABA (CAS 56-12-2) Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global GABA (CAS 56-12-2) Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global GABA (CAS 56-12-2) Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global GABA (CAS 56-12-2) Sales Market Share Forecast by Application (2012-2027)
Table 82: Global GABA (CAS 56-12-2) Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global GABA (CAS 56-12-2) Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: GABA (CAS 56-12-2) Picture
Figure 2: Global GABA (CAS 56-12-2) Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: GABA (CAS 56-12-2) Supply Chain Analysis
Figure 5: GABA (CAS 56-12-2) Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Biological Fermentation
Figure 7: Product Picture of Chemical Synthesis
Figure 8: Global GABA (CAS 56-12-2) Sales Market Share by Type, 2020
Figure 9: Global GABA (CAS 56-12-2) Revenue Market Share by Type, 2020
Figure 10: GABA (CAS 56-12-2) in Pharmaceuticals & Food
Figure 11: Global GABA (CAS 56-12-2) Market: Pharmaceuticals & Food 2016-2021
Figure 12: GABA (CAS 56-12-2) in Animal Feeds
Figure 13: Global GABA (CAS 56-12-2) Market: Animal Feeds 2016-2021
Figure 14: Global GABA (CAS 56-12-2) Sales Market Share by Application, 2020
Figure 15: Global GABA (CAS 56-12-2) Revenue Market Share by Application, 2020
Figure 16: Global GABA (CAS 56-12-2) Sales Market Share by Region 2016-2021
Figure 17: Global GABA (CAS 56-12-2) Revenue Market Share by Region 2016-2021
Figure 18: North America GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 19: North America GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 20: Europe GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 21: Europe GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 24: South America GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 25: South America GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 28: North America GABA (CAS 56-12-2) Sales Market Share by Country, 2020
Figure 29: North America GABA (CAS 56-12-2) Revenue Market Share by Country, 2020
Figure 30: United States GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 31: United States GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 32: Canada GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 33: Canada GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 34: Mexico GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 35: Mexico GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 36: Europe GABA (CAS 56-12-2) Sales Market Share by Country, 2020
Figure 37: Europe GABA (CAS 56-12-2) Revenue Market Share by Country, 2020
Figure 38: Germany GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 39: Germany GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 40: France GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 41: France GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 42: UK GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 43: UK GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 44: Italy GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 45: Italy GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 46: Russia GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 46: Russia GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 47: Spain GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 48: Spain GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific GABA (CAS 56-12-2) Sales Market Share by Country, 2020
Figure 50: Asia Pacific GABA (CAS 56-12-2) Revenue Market Share by Country, 2020
Figure 51: China GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 52: China GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 53: Japan GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 54: Japan GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 55: Korea GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 56: Korea GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 59: India GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 60: India GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 61: Australia GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 62: Australia GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 63: South America GABA (CAS 56-12-2) Sales Market Share by Country, 2020
Figure 64: South America GABA (CAS 56-12-2) Revenue Market Share by Country, 2020
Figure 65: Brazil GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 66: Brazil GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 67: Argentina GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 68: Argentina GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 69: Colombia GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 70: Colombia GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa GABA (CAS 56-12-2) Sales Market Share by Country, 2020
Figure 72: Middle East and Africa GABA (CAS 56-12-2) Revenue Market Share by Country, 2020
Figure 73: Turkey GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 74: Turkey GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 77: South Africa GABA (CAS 56-12-2) Sales (K Units) Status 2016-2021
Figure 78: South Africa GABA (CAS 56-12-2) Revenue (Million USD) Status 2016-2021
Figure 79: Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Revenue Market Share Globally (2019-2021)
Figure 80: Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Revenue Market Share Globally (2019-2021)
Figure 81: Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Revenue Market Share Globally (2019-2021)
Figure 82: Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Revenue Market Share Globally (2019-2021)
Figure 83: Shanghai Richen GABA (CAS 56-12-2) Revenue Market Share Globally (2019-2021)
Figure 84: Sekisui Chemical GABA (CAS 56-12-2) Revenue Market Share Globally (2019-2021)
Figure 85: Pharma Foods International GABA (CAS 56-12-2) Revenue Market Share Globally (2019-2021)
Figure 86: Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Revenue Market Share Globally (2019-2021)
Figure 87: Luoyang Huarong GABA (CAS 56-12-2) Revenue Market Share Globally (2019-2021)
Figure 88: Kyowa Hakko GABA (CAS 56-12-2) Revenue Market Share Globally (2019-2021)
Figure 89: Global GABA (CAS 56-12-2) Sales (K Units) Forecast (2022-2027)
Figure 90: Global GABA (CAS 56-12-2) Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Chemical & Material Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Chemical & Material Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Chemical & Material Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Chemical & Material Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets